RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Name: RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
License: Public Domain

Replimune, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

refractory metastatic colorectal cancer, pmmr, mss

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 125858
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.